SlideShare a Scribd company logo
Coronary Heart Disease
Hawler Medical University
College of Medicine
Community Health
Prepared by:
Hawraz Faris Saadi
BSN, MD Student
11/7/2017 1
Coronary Heart Disease
(ischaemic heart disease) has been defined as
".impairment of heart function due to inadequate
blood flow to the heart compared to its needs,
caused by obstructive changes in the coronary
circulation to the heart"
11/7/2017 2
Coronary Heart Disease Cont.
 It’s the most common form of heart disease and
the single most important cause of premature
death in Europe, Russia, North and South America,
Australia and New Zealand.
 It’s the cause of 25-30% of deaths in most
industrialized countries.
11/7/2017 3
Clinical Problems of CHD :
1. Stable angina
2. Unstable angina
3. Myocardial infarction
4. Heart failure
5. Arrhythmia
6. Sudden death
11/7/2017 4
Risk Factors :
Not Modifiable Modifiable
Age Cigarette smoking
Sex High blood pressure
Family History Elevated serum cholesterol
Genetic Factors
Others (Diabetes, Obesity,
Sedentary habits ,Stress)
11/7/2017 5
1. Smoking
 Smoking damages the lining of arteries, leading to
a build up of fatty material (atheroma) which
narrows the artery.
 The carbon monoxide induced atherogenesis and
in tobacco smoke reduces the amount of oxygen
in the blood. This means the heart has to pump
harder to supply the body with the oxygen it
needs.
11/7/2017 6
1. Smoking Cont.
 The nicotine in cigarettes stimulates the body to
produce adrenaline, which makes the heart beat
faster and raising the blood pressure, making the
heart work harder and raising myocardial oxygen
demand.
11/7/2017 7
1. Smoking Cont.
 The degree of risk developing CHD is directly related
to the number of cigarettes smoked per day.
 Filter cigarettes are probably not protective .
 There is evidence that the influence of smoking is not
only independent of, but also synergistic with other
risk factors such as hypertension and elevated serum
cholesterol.
 This means that the effects are more than additive.
11/7/2017 8
1. Smoking Cont.
 The risk declines quite substantially within one
year of stopping smoking and more gradually
thereafter until, after 10-20 years, it is the same
as that of nonsmokers
11/7/2017 9
2. Hypertension
 The blood pressure is the single most useful test
for identifying individuals at a high risk of
developing CHD.
 Hypertension accelerates the atherosclerotic
process, especially if hyperlipidaemia is also
present and contributes importantly to CHD.
11/7/2017 10
3. Elevated Serum cholesterol
 The elevation of serum cholesterol was one of the
factors which carried an increased risk for the
myocardial infraction.
 the level of low-density lipoprotein (LDL)
cholesterol that is most directly associated with
coronary heart disease.
11/7/2017 11
4. Other risk factor(Diabetes)
 The risk of coronary heart disease is 2-3 times
higher in diabetics than in non-diabetics.
 Coronary heart disease is responsible for 30-50%
of deaths in diabetics over the age of 40 years in
industrialized countries
11/7/2017 12
Epidemiology
 "Epidemics" of coronary heart disease began at
different times in different countries.
 In United States, epidemics began in the early
1920s ,in Britain in the 1930s.
 Countries where the epidemic began earlier are
now showing a decline. For example, in United
States, where the epidemic began in early 1920s,
a steady decline was evident by 1968, and a 25%
fall in mortality
11/7/2017 13
Epidemiology cont.
 Coronary heart disease (CHD) is a major cause of
death and disability in developed countries.
 Although CHD mortality rates worldwide have
declined over the past four decades, CHD remains
responsible for about one-third or more of all deaths
in individuals over age 35.
 It has been estimated that nearly one-half of all
middle-aged men and one-third of middle-aged
women in the United States will develop some
manifestation of CHD.
11/7/2017 14
Prevention of CHD
1. Primordial prevention.
2. Primary prevention.
A. Population strategy.
B. High risk strategy.
3.Secondary prevention.
11/7/2017 15
1. Primordial prevention
 It involves preventing the emergence and spread
of CHD risk factors and life-styles that have not
yet appeared or become endemic.
 This applies to developing countries in particular
because these countries should seek to preserve
their traditional eating patterns and lifestyles
associated with low levels of CHD risk factors.
11/7/2017 16
1. Primordial prevention Cont.
 Since the etiology of CHD is multifactorial the
approach to prevention should be multifactorial
aimed at controlling or modifying as many risk
factors as possible.
 The aim should be to change the community as a
whole, not the individual subjects living in it
11/7/2017 17
2. Primary prevention
a. Population strategy:
The strategy should therefore be based on mass
approach focusing mainly on the control of risk factors
in whole populations, not merely in individuals.
This approach is based on the principle that small
changes in risk factor levels in total populations can
achieve the biggest reduction in mortality
11/7/2017 18
2. Primary prevention Cont.
a. Population strategy: The population strategy
include the following key areas
1. Dietary changes.
2. Smoking.
3. Blood pressure.
4. Physical activity.
11/7/2017 19
1. Dietary changes
Dietary modification is the principal preventive
strategy in the prevention of CHD by :
1. Reduction of fat intake to 20-30% of total energy
intake.
2. consumption of saturated fats must be limited to
less than 10 per cent of total energy intake.
3. Reduction of dietary cholesterol to below 100 mg
per 1000 kcal per day.
11/7/2017 20
1. Dietary changes Cont.
4. increase in complex carbohydrate consumption
(vegetables, fruits, whole grains and legumes).
5. avoidance of alcohol consumption.
6. Reduction of salt intake to 5 g daily or less.
11/7/2017 21
2. Smoking
 The goal should be to achieve a smoke-free
society, and several countries are progressing
towards this goal.
 To achieve the goal of a smoke-free society, a
comprehensive health program would be required
which includes effective information and
education activities
11/7/2017 22
3. Blood pressure
The goal of the population approach to high blood
pressure would thus be to reduce mean population
blood pressure levels. This involves a multifactorial
approach based on a "prudent diet"
11/7/2017 23
4. Physical activity
Regular physical activity should be a part of normal
daily life. It is particularly important to encourage
children to take up physical activities that they can
continue throughout their lives.
11/7/2017 24
B. High risk strategy
1) Identifying risk
2) Specific advice
11/7/2017 25
1) Identifying risk
 High-risk intervention can only start once those at
high risk have been identified.
 By means of simple tests such as blood pressure
and serum cholesterol measurement it is possible
to identify individuals at special risk.
 Individuals at special risk also include those who
smoke, those with a strong family history of CHD,
diabetes and obesity and young women using oral
contraceptives
11/7/2017 26
2) Specific advice
Having identified those at high risk, the next step
will be to bring them under preventive care and
motivate them to take positive action against all
the identified risk factors.
11/7/2017 27
3. Secondary prevention
 Secondary prevention must be seen as a
continuation of primordial prevention and primary
prevention, It forms an important part of an
overall strategy.
 The aim of secondary prevention is to prevent the
recurrence and progression of CHD.
 Despite advances in treatment
11/7/2017 28
References
1. Nicki R., Brian R., Stuart H., (2010) Davidson’s Principles and Practice of
Medicine.
2. Park K. (2015) Park’s textbook of preventive and social medicine.
3. https://www.bhf.org.uk/heart-health/risk-factors/smoking
4. https://www.uptodate.com/contents/epidemiology-of-coronary-heart-
disease
11/7/2017 29
11/7/2017 30

More Related Content

What's hot

Rheumatic heart disease ppt
Rheumatic heart disease pptRheumatic heart disease ppt
Rheumatic heart disease ppt
Harsh Rastogi
 
Rheumatic Heart Disease
 Rheumatic Heart Disease Rheumatic Heart Disease
Rheumatic Heart Disease
Neelu Aryal
 
Congenital heart disease
Congenital heart diseaseCongenital heart disease
CHICKENPOX ppt
CHICKENPOX pptCHICKENPOX ppt
CHICKENPOX ppt
Suraj Ahirwar
 
Diabetes
 Diabetes Diabetes
Imr
ImrImr
Pneumoconiosis
Pneumoconiosis Pneumoconiosis
Pneumoconiosis
Raghavendra Huchchannavar
 
Coronary heart diseases ppt
Coronary heart diseases pptCoronary heart diseases ppt
Coronary heart diseases pptUma Binoy
 
Coronary heart diseases chd
Coronary heart diseases  chdCoronary heart diseases  chd
Coronary heart diseases chd
Dr.Hemant Kumar
 
COPD (Chronic obstructive Pulmonary Disease) PowerPoint Presentation -aslam
COPD  (Chronic obstructive Pulmonary Disease) PowerPoint Presentation -aslamCOPD  (Chronic obstructive Pulmonary Disease) PowerPoint Presentation -aslam
COPD (Chronic obstructive Pulmonary Disease) PowerPoint Presentation -aslam
Dr.Aslam calicut
 
Cerebrovascular accident
Cerebrovascular accidentCerebrovascular accident
Cerebrovascular accident
Abhay Rajpoot
 
Hepatitis
HepatitisHepatitis
Hepatitis
OM VERMA
 
Bronchial asthma
Bronchial asthmaBronchial asthma
Bronchial asthma
ANILKUMAR BR
 
Rheumatic heart disease
Rheumatic heart diseaseRheumatic heart disease
Rheumatic heart disease
Abhay Rajpoot
 
Bronchiectasis
Bronchiectasis Bronchiectasis
Bronchiectasis
ANILKUMAR BR
 
Pneumoconiosis
PneumoconiosisPneumoconiosis
Pneumoconiosis
Eneutron
 
Coronary Artery Disease
Coronary Artery DiseaseCoronary Artery Disease
Coronary Artery Disease
Abhay Rajpoot
 
Epidemiology
EpidemiologyEpidemiology
Epidemiology
frank jc
 

What's hot (20)

Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
Rheumatic heart disease ppt
Rheumatic heart disease pptRheumatic heart disease ppt
Rheumatic heart disease ppt
 
Rheumatic Heart Disease
 Rheumatic Heart Disease Rheumatic Heart Disease
Rheumatic Heart Disease
 
Congenital heart disease
Congenital heart diseaseCongenital heart disease
Congenital heart disease
 
CHICKENPOX ppt
CHICKENPOX pptCHICKENPOX ppt
CHICKENPOX ppt
 
Diabetes
 Diabetes Diabetes
Diabetes
 
Imr
ImrImr
Imr
 
Pneumoconiosis
Pneumoconiosis Pneumoconiosis
Pneumoconiosis
 
Coronary heart diseases ppt
Coronary heart diseases pptCoronary heart diseases ppt
Coronary heart diseases ppt
 
Coronary heart diseases chd
Coronary heart diseases  chdCoronary heart diseases  chd
Coronary heart diseases chd
 
COPD (Chronic obstructive Pulmonary Disease) PowerPoint Presentation -aslam
COPD  (Chronic obstructive Pulmonary Disease) PowerPoint Presentation -aslamCOPD  (Chronic obstructive Pulmonary Disease) PowerPoint Presentation -aslam
COPD (Chronic obstructive Pulmonary Disease) PowerPoint Presentation -aslam
 
Cerebrovascular accident
Cerebrovascular accidentCerebrovascular accident
Cerebrovascular accident
 
Hepatitis
HepatitisHepatitis
Hepatitis
 
Bronchial asthma
Bronchial asthmaBronchial asthma
Bronchial asthma
 
Rheumatic heart disease
Rheumatic heart diseaseRheumatic heart disease
Rheumatic heart disease
 
Bronchiectasis
Bronchiectasis Bronchiectasis
Bronchiectasis
 
Pneumoconiosis
PneumoconiosisPneumoconiosis
Pneumoconiosis
 
Coronary Artery Disease
Coronary Artery DiseaseCoronary Artery Disease
Coronary Artery Disease
 
Bronchitis
BronchitisBronchitis
Bronchitis
 
Epidemiology
EpidemiologyEpidemiology
Epidemiology
 

Similar to Coronary heart disease

coronaryheartdisease-171107150534.pptx
coronaryheartdisease-171107150534.pptxcoronaryheartdisease-171107150534.pptx
coronaryheartdisease-171107150534.pptx
Narvin S
 
The effects of_the_mediterranean_diet_on_chronic_d
The effects of_the_mediterranean_diet_on_chronic_dThe effects of_the_mediterranean_diet_on_chronic_d
The effects of_the_mediterranean_diet_on_chronic_d
Arnon Ngoenyuang
 
Global Burden of Coronary Heart Disease
Global Burden of Coronary Heart DiseaseGlobal Burden of Coronary Heart Disease
Global Burden of Coronary Heart Disease
PERKI Pekanbaru
 
Diabetes
DiabetesDiabetes
Diabetes
hawraz Faris
 
Non communicable disease and risk factors
Non communicable disease and risk factorsNon communicable disease and risk factors
Non communicable disease and risk factors
Rabin Dani
 
STEP.ppt
STEP.pptSTEP.ppt
STEP.ppt
MALATESHUNDI1
 
Presentation on Ischemic Heart Disease
Presentation on Ischemic Heart DiseasePresentation on Ischemic Heart Disease
Presentation on Ischemic Heart Disease
Pratikshya kisiju
 
Diagnosis of Early Risks, Management of Risks, and Reduction of Vascular Dise...
Diagnosis of Early Risks, Management of Risks, and Reduction of Vascular Dise...Diagnosis of Early Risks, Management of Risks, and Reduction of Vascular Dise...
Diagnosis of Early Risks, Management of Risks, and Reduction of Vascular Dise...
asclepiuspdfs
 
Global Heart Health: Evaluating efforts to promote healthy hearts
Global Heart Health: Evaluating efforts to promote healthy heartsGlobal Heart Health: Evaluating efforts to promote healthy hearts
Global Heart Health: Evaluating efforts to promote healthy hearts
The Economist Media Businesses
 
DM and Heart, What more can we do for patient heart.pdf
DM and Heart, What more can we do for patient heart.pdfDM and Heart, What more can we do for patient heart.pdf
DM and Heart, What more can we do for patient heart.pdf
SolidaSakhan
 
The use of mobile solutions in cardiovascular disease trials
The use of mobile solutions in cardiovascular disease trials The use of mobile solutions in cardiovascular disease trials
The use of mobile solutions in cardiovascular disease trials
Vikrant Patnaik
 
A Review Hypertension
A Review HypertensionA Review Hypertension
A Review Hypertension
ijtsrd
 
Respond on two different days who selected different alterations and
Respond on two different days who selected different alterations andRespond on two different days who selected different alterations and
Respond on two different days who selected different alterations and
mickietanger
 
NCDs Burden in Bangladesh
NCDs Burden in BangladeshNCDs Burden in Bangladesh
NCDs Burden in Bangladesh
S.M. Jashim Uddin Razib
 
NEW CARDIOVASCULAR RISK FACTORS.pptx
NEW CARDIOVASCULAR RISK FACTORS.pptxNEW CARDIOVASCULAR RISK FACTORS.pptx
NEW CARDIOVASCULAR RISK FACTORS.pptx
Kemi Adaramola
 
Noncommunicable diseases worldwide 2020
Noncommunicable diseases worldwide 2020Noncommunicable diseases worldwide 2020
Noncommunicable diseases worldwide 2020
PandurangChavan11
 
Coronary heart disease
Coronary heart diseaseCoronary heart disease
Coronary heart disease
drsanjeev15
 
NCD _1.ppt
NCD _1.pptNCD _1.ppt
NCD _1.ppt
AhmedSamir462624
 

Similar to Coronary heart disease (20)

coronaryheartdisease-171107150534.pptx
coronaryheartdisease-171107150534.pptxcoronaryheartdisease-171107150534.pptx
coronaryheartdisease-171107150534.pptx
 
The effects of_the_mediterranean_diet_on_chronic_d
The effects of_the_mediterranean_diet_on_chronic_dThe effects of_the_mediterranean_diet_on_chronic_d
The effects of_the_mediterranean_diet_on_chronic_d
 
Global Burden of Coronary Heart Disease
Global Burden of Coronary Heart DiseaseGlobal Burden of Coronary Heart Disease
Global Burden of Coronary Heart Disease
 
Diabetes
DiabetesDiabetes
Diabetes
 
Non communicable disease and risk factors
Non communicable disease and risk factorsNon communicable disease and risk factors
Non communicable disease and risk factors
 
STEP.ppt
STEP.pptSTEP.ppt
STEP.ppt
 
Presentation on Ischemic Heart Disease
Presentation on Ischemic Heart DiseasePresentation on Ischemic Heart Disease
Presentation on Ischemic Heart Disease
 
Diagnosis of Early Risks, Management of Risks, and Reduction of Vascular Dise...
Diagnosis of Early Risks, Management of Risks, and Reduction of Vascular Dise...Diagnosis of Early Risks, Management of Risks, and Reduction of Vascular Dise...
Diagnosis of Early Risks, Management of Risks, and Reduction of Vascular Dise...
 
Global Heart Health: Evaluating efforts to promote healthy hearts
Global Heart Health: Evaluating efforts to promote healthy heartsGlobal Heart Health: Evaluating efforts to promote healthy hearts
Global Heart Health: Evaluating efforts to promote healthy hearts
 
DM and Heart, What more can we do for patient heart.pdf
DM and Heart, What more can we do for patient heart.pdfDM and Heart, What more can we do for patient heart.pdf
DM and Heart, What more can we do for patient heart.pdf
 
The use of mobile solutions in cardiovascular disease trials
The use of mobile solutions in cardiovascular disease trials The use of mobile solutions in cardiovascular disease trials
The use of mobile solutions in cardiovascular disease trials
 
Needs Paper
Needs PaperNeeds Paper
Needs Paper
 
A Review Hypertension
A Review HypertensionA Review Hypertension
A Review Hypertension
 
Respond on two different days who selected different alterations and
Respond on two different days who selected different alterations andRespond on two different days who selected different alterations and
Respond on two different days who selected different alterations and
 
NCDs Burden in Bangladesh
NCDs Burden in BangladeshNCDs Burden in Bangladesh
NCDs Burden in Bangladesh
 
NEW CARDIOVASCULAR RISK FACTORS.pptx
NEW CARDIOVASCULAR RISK FACTORS.pptxNEW CARDIOVASCULAR RISK FACTORS.pptx
NEW CARDIOVASCULAR RISK FACTORS.pptx
 
Noncommunicable diseases worldwide 2020
Noncommunicable diseases worldwide 2020Noncommunicable diseases worldwide 2020
Noncommunicable diseases worldwide 2020
 
Stay Aware!
Stay Aware!Stay Aware!
Stay Aware!
 
Coronary heart disease
Coronary heart diseaseCoronary heart disease
Coronary heart disease
 
NCD _1.ppt
NCD _1.pptNCD _1.ppt
NCD _1.ppt
 

More from hawraz Faris

Child health care services
Child health care servicesChild health care services
Child health care services
hawraz Faris
 
Human resource management & Committee and teams
Human resource management & Committee and teamsHuman resource management & Committee and teams
Human resource management & Committee and teams
hawraz Faris
 
Conflict management in health care organization
Conflict management in health care organizationConflict management in health care organization
Conflict management in health care organization
hawraz Faris
 
Family planning programme
Family planning programmeFamily planning programme
Family planning programme
hawraz Faris
 
Nutrition During Pregnancy
Nutrition During PregnancyNutrition During Pregnancy
Nutrition During Pregnancy
hawraz Faris
 
Maternal health care [autosaved]
Maternal health care [autosaved]Maternal health care [autosaved]
Maternal health care [autosaved]
hawraz Faris
 
Health planing
Health planingHealth planing
Health planing
hawraz Faris
 
Managment
ManagmentManagment
Managment
hawraz Faris
 
Cancer, lanug cancer , breast cancer, cervix cancer, stomach cancer, colon ca...
Cancer, lanug cancer , breast cancer, cervix cancer, stomach cancer, colon ca...Cancer, lanug cancer , breast cancer, cervix cancer, stomach cancer, colon ca...
Cancer, lanug cancer , breast cancer, cervix cancer, stomach cancer, colon ca...
hawraz Faris
 
Smoking
SmokingSmoking
Smoking
hawraz Faris
 
Peptic ulcer
Peptic ulcerPeptic ulcer
Peptic ulcer
hawraz Faris
 
Obesity
ObesityObesity
Obesity
hawraz Faris
 
Hypertension
HypertensionHypertension
Hypertension
hawraz Faris
 
Stroke
StrokeStroke
Stroke
hawraz Faris
 
Premature death
Premature deathPremature death
Premature death
hawraz Faris
 
Tobacco smoking
Tobacco smokingTobacco smoking
Tobacco smoking
hawraz Faris
 

More from hawraz Faris (17)

Child health care services
Child health care servicesChild health care services
Child health care services
 
Human resource management & Committee and teams
Human resource management & Committee and teamsHuman resource management & Committee and teams
Human resource management & Committee and teams
 
Conflict management in health care organization
Conflict management in health care organizationConflict management in health care organization
Conflict management in health care organization
 
Family planning programme
Family planning programmeFamily planning programme
Family planning programme
 
Nutrition During Pregnancy
Nutrition During PregnancyNutrition During Pregnancy
Nutrition During Pregnancy
 
Maternal health care [autosaved]
Maternal health care [autosaved]Maternal health care [autosaved]
Maternal health care [autosaved]
 
Health planing
Health planingHealth planing
Health planing
 
Managment
ManagmentManagment
Managment
 
Cancer, lanug cancer , breast cancer, cervix cancer, stomach cancer, colon ca...
Cancer, lanug cancer , breast cancer, cervix cancer, stomach cancer, colon ca...Cancer, lanug cancer , breast cancer, cervix cancer, stomach cancer, colon ca...
Cancer, lanug cancer , breast cancer, cervix cancer, stomach cancer, colon ca...
 
Smoking
SmokingSmoking
Smoking
 
Peptic ulcer
Peptic ulcerPeptic ulcer
Peptic ulcer
 
Obesity
ObesityObesity
Obesity
 
COPD
COPDCOPD
COPD
 
Hypertension
HypertensionHypertension
Hypertension
 
Stroke
StrokeStroke
Stroke
 
Premature death
Premature deathPremature death
Premature death
 
Tobacco smoking
Tobacco smokingTobacco smoking
Tobacco smoking
 

Recently uploaded

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 

Recently uploaded (20)

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 

Coronary heart disease

  • 1. Coronary Heart Disease Hawler Medical University College of Medicine Community Health Prepared by: Hawraz Faris Saadi BSN, MD Student 11/7/2017 1
  • 2. Coronary Heart Disease (ischaemic heart disease) has been defined as ".impairment of heart function due to inadequate blood flow to the heart compared to its needs, caused by obstructive changes in the coronary circulation to the heart" 11/7/2017 2
  • 3. Coronary Heart Disease Cont.  It’s the most common form of heart disease and the single most important cause of premature death in Europe, Russia, North and South America, Australia and New Zealand.  It’s the cause of 25-30% of deaths in most industrialized countries. 11/7/2017 3
  • 4. Clinical Problems of CHD : 1. Stable angina 2. Unstable angina 3. Myocardial infarction 4. Heart failure 5. Arrhythmia 6. Sudden death 11/7/2017 4
  • 5. Risk Factors : Not Modifiable Modifiable Age Cigarette smoking Sex High blood pressure Family History Elevated serum cholesterol Genetic Factors Others (Diabetes, Obesity, Sedentary habits ,Stress) 11/7/2017 5
  • 6. 1. Smoking  Smoking damages the lining of arteries, leading to a build up of fatty material (atheroma) which narrows the artery.  The carbon monoxide induced atherogenesis and in tobacco smoke reduces the amount of oxygen in the blood. This means the heart has to pump harder to supply the body with the oxygen it needs. 11/7/2017 6
  • 7. 1. Smoking Cont.  The nicotine in cigarettes stimulates the body to produce adrenaline, which makes the heart beat faster and raising the blood pressure, making the heart work harder and raising myocardial oxygen demand. 11/7/2017 7
  • 8. 1. Smoking Cont.  The degree of risk developing CHD is directly related to the number of cigarettes smoked per day.  Filter cigarettes are probably not protective .  There is evidence that the influence of smoking is not only independent of, but also synergistic with other risk factors such as hypertension and elevated serum cholesterol.  This means that the effects are more than additive. 11/7/2017 8
  • 9. 1. Smoking Cont.  The risk declines quite substantially within one year of stopping smoking and more gradually thereafter until, after 10-20 years, it is the same as that of nonsmokers 11/7/2017 9
  • 10. 2. Hypertension  The blood pressure is the single most useful test for identifying individuals at a high risk of developing CHD.  Hypertension accelerates the atherosclerotic process, especially if hyperlipidaemia is also present and contributes importantly to CHD. 11/7/2017 10
  • 11. 3. Elevated Serum cholesterol  The elevation of serum cholesterol was one of the factors which carried an increased risk for the myocardial infraction.  the level of low-density lipoprotein (LDL) cholesterol that is most directly associated with coronary heart disease. 11/7/2017 11
  • 12. 4. Other risk factor(Diabetes)  The risk of coronary heart disease is 2-3 times higher in diabetics than in non-diabetics.  Coronary heart disease is responsible for 30-50% of deaths in diabetics over the age of 40 years in industrialized countries 11/7/2017 12
  • 13. Epidemiology  "Epidemics" of coronary heart disease began at different times in different countries.  In United States, epidemics began in the early 1920s ,in Britain in the 1930s.  Countries where the epidemic began earlier are now showing a decline. For example, in United States, where the epidemic began in early 1920s, a steady decline was evident by 1968, and a 25% fall in mortality 11/7/2017 13
  • 14. Epidemiology cont.  Coronary heart disease (CHD) is a major cause of death and disability in developed countries.  Although CHD mortality rates worldwide have declined over the past four decades, CHD remains responsible for about one-third or more of all deaths in individuals over age 35.  It has been estimated that nearly one-half of all middle-aged men and one-third of middle-aged women in the United States will develop some manifestation of CHD. 11/7/2017 14
  • 15. Prevention of CHD 1. Primordial prevention. 2. Primary prevention. A. Population strategy. B. High risk strategy. 3.Secondary prevention. 11/7/2017 15
  • 16. 1. Primordial prevention  It involves preventing the emergence and spread of CHD risk factors and life-styles that have not yet appeared or become endemic.  This applies to developing countries in particular because these countries should seek to preserve their traditional eating patterns and lifestyles associated with low levels of CHD risk factors. 11/7/2017 16
  • 17. 1. Primordial prevention Cont.  Since the etiology of CHD is multifactorial the approach to prevention should be multifactorial aimed at controlling or modifying as many risk factors as possible.  The aim should be to change the community as a whole, not the individual subjects living in it 11/7/2017 17
  • 18. 2. Primary prevention a. Population strategy: The strategy should therefore be based on mass approach focusing mainly on the control of risk factors in whole populations, not merely in individuals. This approach is based on the principle that small changes in risk factor levels in total populations can achieve the biggest reduction in mortality 11/7/2017 18
  • 19. 2. Primary prevention Cont. a. Population strategy: The population strategy include the following key areas 1. Dietary changes. 2. Smoking. 3. Blood pressure. 4. Physical activity. 11/7/2017 19
  • 20. 1. Dietary changes Dietary modification is the principal preventive strategy in the prevention of CHD by : 1. Reduction of fat intake to 20-30% of total energy intake. 2. consumption of saturated fats must be limited to less than 10 per cent of total energy intake. 3. Reduction of dietary cholesterol to below 100 mg per 1000 kcal per day. 11/7/2017 20
  • 21. 1. Dietary changes Cont. 4. increase in complex carbohydrate consumption (vegetables, fruits, whole grains and legumes). 5. avoidance of alcohol consumption. 6. Reduction of salt intake to 5 g daily or less. 11/7/2017 21
  • 22. 2. Smoking  The goal should be to achieve a smoke-free society, and several countries are progressing towards this goal.  To achieve the goal of a smoke-free society, a comprehensive health program would be required which includes effective information and education activities 11/7/2017 22
  • 23. 3. Blood pressure The goal of the population approach to high blood pressure would thus be to reduce mean population blood pressure levels. This involves a multifactorial approach based on a "prudent diet" 11/7/2017 23
  • 24. 4. Physical activity Regular physical activity should be a part of normal daily life. It is particularly important to encourage children to take up physical activities that they can continue throughout their lives. 11/7/2017 24
  • 25. B. High risk strategy 1) Identifying risk 2) Specific advice 11/7/2017 25
  • 26. 1) Identifying risk  High-risk intervention can only start once those at high risk have been identified.  By means of simple tests such as blood pressure and serum cholesterol measurement it is possible to identify individuals at special risk.  Individuals at special risk also include those who smoke, those with a strong family history of CHD, diabetes and obesity and young women using oral contraceptives 11/7/2017 26
  • 27. 2) Specific advice Having identified those at high risk, the next step will be to bring them under preventive care and motivate them to take positive action against all the identified risk factors. 11/7/2017 27
  • 28. 3. Secondary prevention  Secondary prevention must be seen as a continuation of primordial prevention and primary prevention, It forms an important part of an overall strategy.  The aim of secondary prevention is to prevent the recurrence and progression of CHD.  Despite advances in treatment 11/7/2017 28
  • 29. References 1. Nicki R., Brian R., Stuart H., (2010) Davidson’s Principles and Practice of Medicine. 2. Park K. (2015) Park’s textbook of preventive and social medicine. 3. https://www.bhf.org.uk/heart-health/risk-factors/smoking 4. https://www.uptodate.com/contents/epidemiology-of-coronary-heart- disease 11/7/2017 29